ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 284751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 284751; 2) Community: the network communities that were significantly associated with the response to NSC 284751; 3) Molecule: the relationships between components within communities and NSC 284751; 4) MDR: the compounds that were significantly associated with the NSC 284751.

NSC Compound Enrichment Correlation
NSC 717468 Null 0.0130238833303634 0.067030409
NSC 718781 Erlotinib hydrochloride 0.0130238833303634 0.039690064
NSC 725098 Null 0.0130238833303634 0.30064079
NSC 726217 Combretastatin A4-analogue 0.0130238833303634 0.25302233
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0130238833303634 0.15163187
NSC 732205 Null 0.0130238833303634 0.45991578
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0130238833303634 0.40025874
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0130238833303634 0.28499454
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0130238833303634 0.35868662
NSC 750050 Null 0.0130238833303634 0.16508405
Total:146  Current:58    [First] [Prev] [Next] [Last]